P27; KIP1 Monoclonal antibody proteintech 67355-1-Ig

$449.00
In stock
SKU
67355-1-Ig

 

CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27, P27KIP1

Host / Isotype: Mouse / IgG1 Class: Monoclonal
Reactivity: Human, Mouse, Rat And More (1) Immunogen: CatNo: Ag14634 Product name: Recombinant human P27; KIP1 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 1-198 aa of BC001971 Sequence: MSNVRVSNGSPSLERMDARQAEHPKPSACRNLFGPVDHEELTRDLEKHCRDMEEASQRKWNFDFQNHKPLEGKYEWQEVEKGSLPEFYYRPPRPPKGACKVPAQESQDGSGSRPAAPLIGAPANSEDTHLVDPKTDPSDSQTGLAEQCAGIRKRPATDDSSTQNKRANRTEENVSDGSPNAGSVEQTPKKPGLRRRQT Predict reactive species
 Applications: WB, ELISA Observed Molecular Weight: 198 aa, 22 kDa
Formulation: PBS, Azide, Glycerol GenBank Accession Number: BC001971
Conjugate: Unconjugated Gene Symbol: p27 Kip1/CDKN1B
Tested Applications: Positive WB detected in Gene ID (NCBI): 1027
Application: Western Blot (WB) RRID: AB_2882610
Dilution: WB : 1:5000-1:10000 Conjugate: Unconjugated
Tested Reactivity: Human, Mouse, Rat Form: Liquid
Host / Isotype: Mouse / IgG1 Background Information: DKN1B, also named as P27 or KIP1, is a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. P27 binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controlling cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Downregulation of P27 has been implicated in the progression of several malignancies, including lung cancer, hepatocellular carcinoma, salivary cancer, oral squamous cell carcinomas, and gastric cancer.

 

 

Reviews

Write Your Own Review
You're reviewing:P27; KIP1 Monoclonal antibody proteintech 67355-1-Ig
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.